Delivery Order SPE2DB24D1021-SPE2DB25FEVFE

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $10,572.09 and is a firm fixed price, delivery order type contract with a period of performance through February 2025. The contract was not set...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $5,162.97 and an ultimate completion date of August 12, 2024. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the specified pharmaceutical item to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $1,526.34 and an ultimate completion date of February 14, 2025. It is a firm-fixed-price contract and was not set aside for any particular business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,155.60 firm-fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. The award has an ultimate completion date of January 14, 2025. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The award has a ceiling value of $3,673.98 and an ultimate completion date of February 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a ceiling value of $2,357.00 and runs through December 6, 2024. It is a Firm Fixed Price contract and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Aimovig 140 mg/mL autoinjectors, a specialty medication. The contract has a total ceiling value of $6,450.66 and a period of performance through November 18, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML autoinjectors, with a ceiling value of $6,954.67 and a period of performance through January 14, 2025. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $1,190.48 and a completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.08, is for the procurement of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price, delivery order with an ultimate completion date of March 12, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEVFE
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has a ceiling value of $9,687.53 and a completion date of March 25, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/29/25, 1:29 AM